Team:GeorgiaTech/Ethics and Safety
From 2010.igem.org
Aschwartz9 (Talk | contribs) |
|||
(16 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | <div id="container"><div id="header">[[Image: | + | <div id="container"><div id="header">[[Image:bannerhome.jpg|965px|logo]] |
<html> | <html> | ||
<style type="text/css"> | <style type="text/css"> | ||
<!-- | <!-- | ||
+ | |||
+ | a, a:hover, a:visited{ | ||
+ | color: white; | ||
+ | font-weight: bold; | ||
+ | text-decoration: underline; | ||
+ | } | ||
+ | a:hover { | ||
+ | color: black; | ||
+ | } | ||
body | body | ||
Line 16: | Line 25: | ||
table | table | ||
{ | { | ||
- | background-color: # | + | background-color: #964141; |
font-color: white; | font-color: white; | ||
- | color: # | + | color: #964141; |
} | } | ||
Line 25: | Line 34: | ||
#bodyContent | #bodyContent | ||
{ | { | ||
- | background-color: | + | background-color: ; |
color: white; | color: white; | ||
} | } | ||
Line 43: | Line 52: | ||
p | p | ||
{ | { | ||
- | background-color: # | + | background-color: #964141; |
color: white; | color: white; | ||
} | } | ||
Line 74: | Line 83: | ||
</body> | </body> | ||
- | |||
- | <p>< | + | <p><center><font color="#FFFFFF" size=5><b>Safety Training</b></font></center></p> |
- | <table border="2" cellpadding ="5" cellspacing = "5"> | + | |
- | <tr><th><FONT COLOR="#FFFFFF"> | + | <table width="965" border="0" cellpadding="0" cellspacing="0"> |
+ | <tr> | ||
+ | <td bgcolor="#7c1212" width="965"><font color="#FFFFFF"><p></p></font></td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | |||
+ | <center><table border="2" cellpadding ="5" cellspacing = "5"> | ||
+ | <tr><th><FONT COLOR="#FFFFFF">Team Member</FONT></th><th><FONT COLOR="#FFFFFF">Training</FONT></th></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Mitesh Agrawal</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Margo Clark</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Robert Fee</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Christina Graves</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Atta Hassan</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Scott Holmes</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Monica Huynh</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Gita Mahmoudabadi</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
+ | <tr><td><FONT COLOR="#FFFFFF">Christian Mandrycky</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
<tr><td><FONT COLOR="#FFFFFF">Debika Mitra</FONT></td><td><FONT COLOR="#FFFFFF">MSE Safety Training</FONT></td></tr> | <tr><td><FONT COLOR="#FFFFFF">Debika Mitra</FONT></td><td><FONT COLOR="#FFFFFF">MSE Safety Training</FONT></td></tr> | ||
- | <tr><td><FONT COLOR="#FFFFFF">Amy Schwartz</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | + | <tr><td><FONT COLOR="#FFFFFF">Amy Schwartz</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> |
- | <tr><td><FONT COLOR="#FFFFFF"> | + | <tr><td><FONT COLOR="#FFFFFF">Shadeah Suleiman</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<tr><td><FONT COLOR="#FFFFFF">Sid Tantia</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | <tr><td><FONT COLOR="#FFFFFF">Sid Tantia</FONT></td><td><FONT COLOR="#FFFFFF">Marc Pline's Bio Safety Training</FONT></td></tr> | ||
- | + | </table> </center> | |
- | + | ||
<p> | <p> | ||
Note: Marc Pline is from the GT School of Biology | Note: Marc Pline is from the GT School of Biology | ||
- | </p> | + | </p></center> |
- | + | <table width="965" border="0" cellpadding="0" cellspacing="0"> | |
+ | <tr> | ||
<td bgcolor="#7c1212" width="965"><font color="#FFFFFF"><p></p></font></td> | <td bgcolor="#7c1212" width="965"><font color="#FFFFFF"><p></p></font></td> | ||
</tr> | </tr> | ||
Line 98: | Line 118: | ||
<hr> | <hr> | ||
- | |||
<table width="965" border="0" cellpadding="0" cellspacing="0"> | <table width="965" border="0" cellpadding="0" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 104: | Line 123: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | <p><center><font color="#FFFFFF" size=5><b> | + | |
+ | <p><center><font color="#FFFFFF" size=5><b>Questions About Ethics and Safety</b></font></center></p> | ||
+ | |||
<table width="965" border="0" cellpadding="0" cellspacing="0"> | <table width="965" border="0" cellpadding="0" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 110: | Line 131: | ||
</tr> | </tr> | ||
</table> | </table> | ||
+ | |||
<center><table width="900" border="0" cellpadding="2" cellspacing="10"> | <center><table width="900" border="0" cellpadding="2" cellspacing="10"> | ||
<tr> | <tr> | ||
- | <td bgcolor="#964141" width=" | + | <td bgcolor="#964141" width="900"><font color="#FFFFFF"><b><p>1. Would any of your project ideas raise safety issues in terms of:</p> |
- | + | ||
- | + | ||
<ul><font color="#FFFFFF"> | <ul><font color="#FFFFFF"> | ||
<li>researcher safety,</li> | <li>researcher safety,</li> | ||
<li>public safety, or</li> | <li>public safety, or</li> | ||
<li>environmental safety?</li> | <li>environmental safety?</li> | ||
- | </ul> | + | </ul></b> |
- | <p> | + | <p>The Georgia Tech iGem project involves bacterial thermogenesis via cloning of a naturally occuring plant gene. All genetic parts involved are found currently in natural plants or bacteria and none pose a threat to environmental, public, or researcher safety. All bacteria strains used are nonpathogenic. Further, it is highly unlikely that genes under experimentation would cause adverse effects even if expressed in wild type bacterial colonies, as the heat production is both benign and extremely energy intensive, which would be a highly unfavorable trait. All laboratory materials, both biological and chemical, are safely used in a Biosafety Level 1 laboratory setting.</p> |
- | + | ||
- | + | ||
- | is | + | |
- | + | ||
- | + | ||
- | + | ||
- | used in a Biosafety Level 1 laboratory setting.</p> | + | |
- | <p>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</p> | + | <p><b>2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,</p> |
<ul><font color="#FFFFFF"> | <ul><font color="#FFFFFF"> | ||
<li>Did you document these issues in the Registry?</li> | <li>Did you document these issues in the Registry?</li> | ||
<li>How did you manage to handle the safety issue?</li> | <li>How did you manage to handle the safety issue?</li> | ||
<li>How could other teams learn from your experience?</li> | <li>How could other teams learn from your experience?</li> | ||
- | </ul> | + | </ul></b> |
- | <p> | + | <p>The BioBrick device constructs contain an alternative oxidase gene (AOX) attached to a targeting sequence (OmpA) with a promoter, HybB; none of these known biosafety issues.</p> |
- | promoter, HybB | + | |
- | <p>3. Is there a local biosafety group, committee, or review board at your institution?</p> | + | <p><b>3. Is there a local biosafety group, committee, or review board at your institution?</p> |
<ul><font color="#FFFFFF"> | <ul><font color="#FFFFFF"> | ||
Line 145: | Line 158: | ||
<li>If no, which specific biosafety rules or guidelines do you have to consider in your | <li>If no, which specific biosafety rules or guidelines do you have to consider in your | ||
country?</li> | country?</li> | ||
- | </ul> | + | </ul></b> |
- | <p>The Occupational Health and Safety Committee and the Environmental Health and Safety Office | + | <p>The Occupational Health and Safety Committee and the Environmental Health and Safety Office of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for Biosafety Level 1 Research.</p> |
- | of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for | + | |
- | Biosafety Level 1 Research.</p> | + | |
- | <p>4. Do you have any other ideas how to deal with safety issues that could be useful for future | + | <p><b>4. Do you have any other ideas how to deal with safety issues that could be useful for future |
iGEM competitions? How could parts, devices and systems be made even safer through | iGEM competitions? How could parts, devices and systems be made even safer through | ||
- | biosafety engineering?</p> | + | biosafety engineering?</p></b> |
- | <p>Our group has discussed the sharp learning curve associated with the first year of a team’s experience | + | <p>Our group has discussed the sharp learning curve associated with the first year of a team’s experience with iGEM. All group members attended an institute biological laboratory safety class, but many things were learned along the way, specific to genetic engineering research. We would propose a collaboration of iGEM members to produce an online, visual, one-hour introductory course on the basic biosafety issues that could arise during the iGEM research process.</p> |
- | with iGEM. | + | </tr> |
- | + | </table></center> | |
- | genetic engineering | + | |
- | online, visual, one-hour introductory course on the basic biosafety issues that could arise during the | + | |
- | iGEM research process.</p> | + | <table width="965" border="0" cellpadding="0" cellspacing="0"> |
+ | <tr> | ||
+ | <td bgcolor="#7c1212" width="965"><font color="#FFFFFF"><p></p></font></td> | ||
+ | </tr> | ||
+ | </table> | ||
<hr> | <hr> |
Latest revision as of 02:42, 28 October 2010
Team Member | Training |
---|---|
Mitesh Agrawal | Marc Pline's Bio Safety Training |
Margo Clark | Marc Pline's Bio Safety Training |
Robert Fee | Marc Pline's Bio Safety Training |
Christina Graves | Marc Pline's Bio Safety Training |
Atta Hassan | Marc Pline's Bio Safety Training |
Scott Holmes | Marc Pline's Bio Safety Training |
Monica Huynh | Marc Pline's Bio Safety Training |
Gita Mahmoudabadi | Marc Pline's Bio Safety Training |
Christian Mandrycky | Marc Pline's Bio Safety Training |
Debika Mitra | MSE Safety Training |
Amy Schwartz | Marc Pline's Bio Safety Training |
Shadeah Suleiman | Marc Pline's Bio Safety Training |
Sid Tantia | Marc Pline's Bio Safety Training |
Note: Marc Pline is from the GT School of Biology
1. Would any of your project ideas raise safety issues in terms of:
The Georgia Tech iGem project involves bacterial thermogenesis via cloning of a naturally occuring plant gene. All genetic parts involved are found currently in natural plants or bacteria and none pose a threat to environmental, public, or researcher safety. All bacteria strains used are nonpathogenic. Further, it is highly unlikely that genes under experimentation would cause adverse effects even if expressed in wild type bacterial colonies, as the heat production is both benign and extremely energy intensive, which would be a highly unfavorable trait. All laboratory materials, both biological and chemical, are safely used in a Biosafety Level 1 laboratory setting. 2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
The BioBrick device constructs contain an alternative oxidase gene (AOX) attached to a targeting sequence (OmpA) with a promoter, HybB; none of these known biosafety issues. 3. Is there a local biosafety group, committee, or review board at your institution?
The Occupational Health and Safety Committee and the Environmental Health and Safety Office of the Georgia Institute of Technology has approved Professor Eric Gaucher’s laboratory for Biosafety Level 1 Research. 4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? Our group has discussed the sharp learning curve associated with the first year of a team’s experience with iGEM. All group members attended an institute biological laboratory safety class, but many things were learned along the way, specific to genetic engineering research. We would propose a collaboration of iGEM members to produce an online, visual, one-hour introductory course on the basic biosafety issues that could arise during the iGEM research process. |